We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
German American Bancorp
GABC
$1.92B
| $264K | ﹤0.01% |
13,515
-38
| -0.3% | -$743 |
|
|
QUOT
2552
DELISTED
Quotient Technology Inc
QUOT
| $264K | ﹤0.01% |
29,347
-1,261
| -4% | -$12.4K |
|
2553
Coherus Oncology
CHRS
$222M
| $263K | ﹤0.01% |
13,139
+573
| +5% | +$17.4K |
|
2554
Inovio Pharmaceuticals
INO
$84.7M
| $263K | ﹤0.01% |
3,787
-72
| -2% | -$6.27K |
|
|
WLH
2555
DELISTED
WILLIAM LYON HOMES
WLH
| $263K | ﹤0.01% |
12,757
+672
| +6% | +$16K |
|
2556
AeroVironment
AVAV
$7.91B
| $262K | ﹤0.01% |
13,078
+115
| +0.9% | +$2.8K |
|
2557
Hawkins
HWKN
$2.99B
| $262K | ﹤0.01% |
13,598
+122
| +0.9% | +$2.31K |
|
|
RTEC
2558
DELISTED
Rudolph Technologies Inc
RTEC
| $262K | ﹤0.01% |
21,062
-1,089
| -5% | -$13.4K |
|
2559
Movado Group
MOV
$846M
| $261K | ﹤0.01% |
10,095
-805
| -7% | -$20.9K |
|
2560
American Public Education
APEI
$917M
| $260K | ﹤0.01% |
11,107
-306
| -3% | -$7.31K |
|
2561
Kelly Services Class A
KELYA
$560M
| $260K | ﹤0.01% |
18,411
-529
| -3% | -$7.71K |
|
2562
Waterstone Financial
WSBF
$372M
| $260K | ﹤0.01% |
19,271
-1,495
| -7% | -$19.5K |
|
2563
Dime Commercial Bancshares
DCOM
$1.8B
| $259K | ﹤0.01% |
9,706
+1,643
| +20% | +$44.1K |
|
|
SRG
2564
Seritage Growth Properties
SRG
$129M
| $259K | ﹤0.01% |
+6,956
| New | +$276K |
|
|
FNBC
2565
DELISTED
First NBC Bank Holding Company
FNBC
| $258K | ﹤0.01% |
7,371
-387
| -5% | -$14K |
|
2566
First Bancorp
FBP
$4.47B
| $257K | ﹤0.01% |
72,110
-702,574
| -91% | -$2.85M |
|
2567
NRC Health Common Stock
NRC
$503M
| $257K | ﹤0.01% |
21,498
-1,035
| -5% | -$13.7K |
|
2568
Omeros
OMER
$816M
| $257K | ﹤0.01% |
23,460
-598
| -2% | -$9.31K |
|
|
SPPI
2569
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $257K | ﹤0.01% |
43,003
-105,580
| -71% | -$733K |
|
2570
CEVA Inc
CEVA
$883M
| $256K | ﹤0.01% |
13,809
-266
| -2% | -$4.9K |
|
2571
Middlesex Water
MSEX
$1.08B
| $255K | ﹤0.01% |
10,713
-213
| -2% | -$4.89K |
|
2572
OFG Bancorp
OFG
$2.24B
| $253K | ﹤0.01% |
28,968
-961
| -3% | -$8.27K |
|
2573
Peoples Bancorp
PEBO
$1.52B
| $253K | ﹤0.01% |
12,154
+1,097
| +10% | +$24K |
|
|
AERI
2574
DELISTED
Aerie Pharmaceuticals
AERI
| $253K | ﹤0.01% |
14,238
+1,487
| +12% | +$26.9K |
|
2575
Preferred Bank
PFBC
$1.25B
| $252K | ﹤0.01% |
7,971
-644
| -7% | -$19.8K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.